Recombinant human activated protein C treatment of septic shock syndrome in a patient at 18th week of gestation: A case report

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 3, 2005, Pages 864-865

  Medve, László ^a   Csitári, István Kis ^a   Molnár, Zsolt ^b   László, Ádám ^c  

^a Szent Laszlo Hospital   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c BAJCSY ZSILINSZKY HOSPITAL   (Hungary)

Author keywords

Activated protein C therapy; Pregnancy; Septic shock syndrome

Indexed keywords

ACTIVATED PROTEIN C;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ESCHERICHIA COLI; FEMALE; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

ADULT; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, SECOND; PROTEIN C; RECOMBINANT PROTEINS; SHOCK, SEPTIC; URINARY TRACT INFECTIONS;

EID: 24344457725     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.04.046     Document Type: Article

References (3)

1. R.P. Dellinger, J. Carlet, H. Masur, H. Gerlach, T. Calandra, and J. Cohen Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Crit Care Med 32 2004 858 872
2. G.R. Bernard, J.L. Vincent, and P.F. Laterre Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 2001 699 709
3. P. von Dadelszen, L.A. Magee, S.K. Lee, S.D. Stewart, S. Simone, and G. Koren Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med 30 2002 1883 1892